Remi-Martin Laberge

Remi-Martin Laberge is a seasoned professional in the field of biochemistry and drug discovery, co-founding Arda Therapeutics in January 2022 where roles include Co-Founder and CTO, as well as Senior Vice President and Head of Research. With extensive experience since February 2012 as a Scientific Advisor for RML Consulting, Laberge has contributed to advancing chronic and age-related disease research. Previous positions include Vice-President of Scientific Operations at IRICoR, managing numerous drug discovery programs, and leading research teams at UNITY Biotechnology, focusing on cellular biology and senolytic molecule development. Laberge also held roles at the Buck Institute for Research on Aging, conducting NIH-funded research on aging, and has a robust educational background with a PhD and MSc in Biochemistry from McGill University and Université de Sherbrooke, respectively.